Pharmacologic Therapy of Chronic Heart Failure

Author： Hamad Eman   Mather Paul J.   Srinivasan Siva   Rubin Sharon   Whellan David J.   Feldman Arthur M.  

Publisher： Adis International

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.7, Iss.4, 2007-01, pp. : 235-248

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunomodulation therapy in patients with chronic heart failure

By  

Inpharma, Vol. 1, Iss. 1622, 2008-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Future prospects of anticytokine therapy in chronic heart failure

By von Haehling Stephan   Anker Stefan D  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 2, 2005-02 ,pp. : 163-176

Informa Healthcare

Access to resources Recommend Favorite

Adenosine therapy: a new approach to chronic heart failure

By Kitakaze M.   Hori M.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 11, 2000-11 ,pp. : 2519-2535

Informa Healthcare

Access to resources Recommend Favorite

Cardiac Resynchronization Therapy in Patients with Chronic Heart Failure: Pathophysiology and Current Experience

By Seidl K.   Rameken M.   Vater M.   Senges J.  

American Journal of Cardiovascular Drugs, Vol. 2, Iss. 4, 2002-01 ,pp. : 219-226

Adis International

Access to resources Recommend Favorite

Chronic Heart Failure: Current Evidence, Challenges to Therapy, and Future Directions

By Morrissey Ryan P.   Czer Lawrence   Shah Prediman K.  

American Journal of Cardiovascular Drugs, Vol. 11, Iss. 3, 2011-06 ,pp. : 153-171

Adis International

Access to resources Recommend Favorite